Massachusetts General hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT02210039
The study is being done to test the feasibility and tolerability of a SECM imaging probe in patients with Barrett's Esophagus (BE).
Subjects will undergo SECM probe imaging while they are under conscious sedation. Spiral SECM imaging will be performed continuously over a pre-determined length. Patients will later be asked for their feedback.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Subjects with a previous diagnosis of Barrett's Esophagus will be recruited in the study and undergo SECM probe imaging while using conscious sedation, pulse oximetry and blood pressure monitoring. The probe will be inserted the predetermined required distance in the esophagus using a guide wire.
Once the SECM imaging probe is in place, spiral SECM image data will be continuously collected over a pre-determined length (approximately 5cm).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Imaging of the esophagus using SECM probe and system.
Time frame: During the procedure
We were monitoring the number of participants able to tolerate the procedure. All six participating subjects have been asked for a feedback about tolerability of the procedure using a specific tolerability questionnaire.
Massachusetts General Hospital
Other
Pilot Study to Image the Esophagus Using a SECM Probe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04880044
Barrett Esophagus, Barrett's Esophagus
Cleveland, Ohio, United States
View Trial DetailsNCT04408105
Adenocarcinoma Of Esophagus, Barrett Esophagus
Aurora, Colorado, United States
View Trial DetailsNCT02534233
Barrett Esophagus, Barrett's Esophagus
Baltimore, Maryland, United States
View Trial DetailsNCT05965921
Barrett Esophagus, Barrett's Esophagus
Portsmouth, Hampshire, United Kingdom
View Trial Details